Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: Is it predictive of surgical outcome?

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Li, Binkui ^a   Yuan, Yunfei ^a   Chen, Guihua ^b   He, Liru ^a   Zhang, Yaqi ^a   Li, Jinqing ^a   Li, Guohui ^a   Lau, Wan Y ^c  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Prince of Wales Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PREDICTION; PROGNOSIS; LIVER TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77957359375     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-535     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576. 10.1053/j.gastro.2007.04.061, 17570226.
3. Henderson J, Sherman M, Tavill A, Abecassis M, Chejfec G, Gramlich T. AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford) 2003, 5:243-250. 2020604, 18332995.
4. Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 2007, 245:909-922. 10.1097/01.sla.0000254368.65878.da, 1876960, 17522517.
5. Kee KM, Wang JH, Lee CM, Chen CL, Changchien CS, Hu TH, Cheng YF, Hsu HC, Wang CC, Chen TY, et al. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer 2007, 120:2650-2655. 10.1002/ijc.22616, 17304512.
6. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002, 20:1527-1536. 10.1200/JCO.20.6.1527, 11896101.
7. Poon RT, Fan ST, Ng IO, Wong J. Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification. Ann Surg 2003, 237:376-383. 10.1097/00000658-200303000-00012, 1514304, 12616122.
8. Greene FL, Page DL, Fleming ID, . eds AJCC cancer staging manual. 2002, 131-44. Chicago: Springer, 6, eds.
9. Sobin LH, Wittekind C, . eds UICC TNM Classification of Malignant Tumors. 2002, 81-6. New York: John Wiley & Sons, 6, eds.
10. Tung WY, Chau GY, Loong CC, Wu JC, Tsay SH, King KL, Huang SM, Chiu JH, Wu CW, Lui WY. Surgical resection of primary hepatocellular carcinoma extending to adjacent organ(s). Eur J Surg Oncol 1996, 22:516-520. 10.1016/S0748-7983(96)93056-5, 8903496.
11. Lau WY, Leung KL, Leung TW, Liew CT, Chan M, Li AK. Resection of hepatocellular carcinoma with diaphragmatic invasion. Br J Surg 1995, 82:264-266. 10.1002/bjs.1800820242, 7749707.
12. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000, 31:864-871. 10.1053/he.2000.5852, 10733541.
13. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000, 89:500-507. 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O, 10931448.
14. Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M, Kitano S. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study. Eur J Surg Oncol 2009, 35:174-179.
15. Gospodarowicz MK, Miller D, Groome PA, Greene FL, Logan PA, Sobin LH. The process for continuous improvement of the TNM classification. Cancer 2004, 100:1-5. 10.1002/cncr.11898, 14692017.
16. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, Giulini SM. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 2006, 243:229-235. 10.1097/01.sla.0000197706.21803.a1, 1448919, 16432356.
17. Sonoyama T, Ochiai T, Hironaka T, Yamagishi H. Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma. Hepatogastroenterology 2003, 50:1078-1084.
18. Wilkens L, Bredt M, Flemming P, Klempnauer J, Heinrich Kreipe H. Differentiation of multicentric origin from intra-organ metastatic spread of hepatocellular carcinomas by comparative genomic hybridization. J Pathol 2000, 192:43-51. 10.1002/1096-9896(2000)9999:9999<::AID-PATH671>3.0.CO;2-Z, 10951399.
19. Li Q, Wang J, Juzi JT, Sun Y, Zheng H, Cui Y, Li H, Hao X. Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma. J Gastrointest Surg 2008, 12:1540-1547. 10.1007/s11605-008-0591-y, 18629593.
20. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999, 229:216-222. 10.1097/00000658-199902000-00009, 1191634, 10024103.
21. Usatoff V, Isla AM, Habib NA. Liver resection in advanced hepatocellular carcinoma. Hepatogastroenterology 2001, 48:46-50.
22. Ikai I, Yamaoka Y, Yamamoto Y, Ozaki N, Sakai Y, Satoh S, Shinkura N, Yamamoto M. Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg 1998, 227:433-439. 10.1097/00000658-199803000-00016, 1191282, 9527067.
23. Shimada M, Takenaka K, Kawahara N, Kajiyama K, Yamamoto K, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K. Surgical treatment strategy for patients with stage IV hepatocellular carcinoma. Surgery 1996, 119:517-522. 10.1016/S0039-6060(96)80260-1, 8619206.
24. Chirica M, Scatton O, Massault PP, Aloia T, Randone B, Dousset B, Legmann P, Soubrane O. Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery?. Arch Surg 2008, 143:538-543. discussion 543, 10.1001/archsurg.143.6.538, 18559745.
25. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, Imamura H, Sugawara Y, Kokudo N, Makuuchi M. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 2008, 134:1908-1916. 10.1053/j.gastro.2008.02.091, 18549877.
26. Hasegawa K, Kokudo N. Surgical treatment of hepatocellular carcinoma. Surg Today 2009, 39:833-843. 10.1007/s00595-008-4024-z, 19784720.
27. Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, Ikai I, Yamaoka Y, Curley SA, Nagorney DM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005, 12:364-373. 10.1245/ASO.2005.06.004, 15915370.
28. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008, 48(Suppl 1):S20-37. 10.1016/j.jhep.2008.01.022, 18304676.
29. Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008, 48:1312-1327. 10.1002/hep.22506, 2597642, 18821591.
30. Okada S, Okazaki N, Nose H, Yoshimori M, Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 1992, 16:112-117. 10.1002/hep.1840160119, 1377657.
31. Raoul JL, Guyader D, Bretagne JF, Duvauferrier R, Bourguet P, Bekhechi D, Deugnier YM, Gosselin M. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994, 35:1782-1787.
32. Akashi Y, Koreeda C, Enomoto S, Uchiyama S, Mizuno T, Shiozaki Y, Sameshima Y, Inoue K. Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology 1991, 14:262-268. 10.1002/hep.1840140210, 1650325.
33. Ikai I, Yamamoto Y, Yamamoto N, Terajima H, Hatano E, Shimahara Y, Yamaoka Y. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am 2003, 12:65-75. 10.1016/S1055-3207(02)00082-0, 12735130.
34. Pawlik TM, Poon RT, Abdalla EK, Ikai I, Nagorney DM, Belghiti J, Kianmanesh R, Ng IO, Curley SA, Yamaoka Y, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 2005, 137:403-410. 10.1016/j.surg.2004.12.012, 15800485.
35. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359:378-390. 10.1056/NEJMoa0708857, 18650514.